Prescription questions? Call our speciality pharmacy.
1-888-855-RARE (7273) Mon-Fri 8 AM to 8 PM ET
1-855-813-2039 Fax
Product related questions?

R.A.R.E.® Support for Getting Patients Started

Providing access, tools, and resources for ISTURISA® (osilodrostat), SIGNIFOR® LAR (pasireotide), and SIGNIFOR® (pasireotide).

Getting a Patient Started

The essential forms and resources to help you start and support therapy.

Access and Enrollment

ISTURISA
Patient Prescription Form
ISTURISA
Quick Start Guide
ISTURISA
Letter of Medical Necessity
ISTURISA
Letter of Appeal

Patient Support

ISTURISA
R.A.R.E. Patient Support Program
ISTURISA
Patient Brochure
ISTURISA
Symptom & Self-Monitoring Diary
ISTURISA
Connecting Patients with Other Patients

Additional Resources

ISTURISA
Medical Inquiries
ISTURISA
Adverse Event Reporting

Access and Enrollment

SIGNIFOR LAR
Patient Prescription Form
SIGNIFOR LAR
Preparation and Administration Video
SIGNIFOR LAR
Letter of Medical Necessity: Indication 1
SIGNIFOR LAR
Letter of Medical Necessity: Indication 2
SIGNIFOR LAR
Letter of Appeal: Indication 1
SIGNIFOR LAR
Letter of Appeal: Indication 2
SIGNIFOR LAR
Mobile Injection Program

Patient Support

SIGNIFOR LAR
R.A.R.E. Patient Support Program

Additional Resources

SIGNIFOR LAR
Medical Inquiries
SIGNIFOR LAR
Adverse Event Reporting

Access and Enrollment

SIGNIFOR
Patient Prescription Form

Patient Support

SIGNIFOR
R.A.R.E. Patient Support Program

Additional Resources

SIGNIFOR
Medical Inquiries
SIGNIFOR
Adverse Event Reporting

Patient Enrollment Instructions

All prescriptions are filled through our specialty pharmacy. To get a patient started, submit a Patient Prescription Form.

Step 1: Fill out a patient prescription form.
Download form.

Step 2: Submit the form.
Fax the fully completed Patient Prescription Form to Anovo Specialty Rx at 1-855-813-2039 (NCPDP #: 4445640)

Or, electronically submit the form in your EMR system. When ordering, choose Anovo#5 (NCPDP #: 4445640)

Patient Liaison services are provided to help support patients while on select Recordati Rare Diseases therapies. Information provided by the PL Program is for educational purposes only and is not intended to replace the advice of the health care provider.

Recordati Rare Diseases offers a

$20 co-pay

for eligible patients with commercial insurance*

*Eligibility requirements, restrictions and limitations apply.

R.A.R.E. Patient Support Program

A collaboration of support and services for you, your staff, and your patients.

Access and financial assistance icon

Access and financial assistance

Our reimbursement team will help:

  • Provide information and support for any Prior Authorization and Appeal requirement
  • Investigate patient insurance benefits
  • Administrate co-pay assistance for eligible insured patients and help patients identify other potential assistance opportunities
Dispensing and delivery icon

Dispensing and delivery

Our trained pharmacy team will help:

  • Patients receive treatment on time with overnight delivery
  • Educate about treatment and answer patients’ questions before the first prescription is dispensed
  • Provide 24/7 pharmacy support
Education and adherence icon

Education and adherence

Our R.A.R.E. clinical nurse educator* will make regular phone calls to:

  • Assess adherence, answer questions, and assess patients’ therapy satisfaction
  • Provide education and answer questions about their condition and therapy
  • Alert you if they become aware of any issues that require your attention
*These services are provided at no additional cost to your patients by Recordati Rare Diseases to help them manage their therapy. Information provided by the clinical nurse educator is for educational purposes only and is not intended to replace the advice of patients’ healthcare providers.

Visit one of our product websites:

DISCLAIMER

This site contains medical information that is intended for Healthcare Professionals in the United States only and is not meant to substitute for the advice provided by a medical professional. All decisions regarding patient care should be made considering the unique characteristics of the patient.

Use and access of this site is subject to the terms and conditions as set out in our PRIVACY POLICY and TERMS OF USE.